Public Knowledge-Based Filing OK’ed for Busulfex Use in Lymphoma HSCT

August 27, 2019
Meeting of Council on Unapproved Drugs and Indications with Unmet Medical Needs on Aug 26 A health ministry panel on August 26 agreed that the filing of a public knowledge-based application would be appropriate for Otsuka Pharmaceutical’s cancer drug Busulfex...read more